Japan, March 5 -- ALZPATH INC has got intellectual property rights for 'PHOSPHO-TAU ANTIBODIES AND METHODS OF USE.' Other related details are as follows:
Application Number: JP,2025-115822
Category (FI): G01N33/577@B,C07K16/18,G01N33/53@D
Stage: PROBLEM TO BE SOLVED: To provide phospho-tau antibodies, and to provide methods of use thereof.SOLUTION: Provided herein are compositions and methods relating to improved assays for establishing Alzheimer's disease. Further provided herein are compositions and methods comprising improved antibodies for assays including immunoassays. Provided herein is a method for detecting phosphorylated tau in a sample from an individual comprising: performing an immunoassay on the sample using an antibody or antibody fragment comprising a variable domain, heavy chain region (VH) and a variable domain, light chain region (VL), the VH comprising an amino acid sequence at least about 90% identical to a sequence as set forth in any one of SEQ ID NOs: 30 to 34, and the VL comprising an amino acid sequence at least about 90% identical to a sequence as set forth in any one of SEQ ID NOs: 35 to 40.SELECTED DRAWING: None (Grant)
Filing Date: July 9, 2025
Publication Date: Sept. 19, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
